CN100347302C - Nikkomycin biological synthesis regulating gene and its coded protein and engineering bacterium for expression - Google Patents
Nikkomycin biological synthesis regulating gene and its coded protein and engineering bacterium for expression Download PDFInfo
- Publication number
- CN100347302C CN100347302C CNB2004100584112A CN200410058411A CN100347302C CN 100347302 C CN100347302 C CN 100347302C CN B2004100584112 A CNB2004100584112 A CN B2004100584112A CN 200410058411 A CN200410058411 A CN 200410058411A CN 100347302 C CN100347302 C CN 100347302C
- Authority
- CN
- China
- Prior art keywords
- leu
- ala
- arg
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention a specific regulatory gene of Nikkomycin through a biosyntheticpathway, a coding protein of the specific regulatory gene and the application of the specific regulatory gene. The gene of the present invention is one of the following nucleotide sequences: 1. SEQ ID No. 1 in a sequence table, 2. polyribonucleotide of the protein sequence of SEQ ID No. 2 of a coding sequence table, 3. a DNA sequence which has the homology of more than 90% with a DNA sequence limited by the SEQ ID No. 1 in the sequence table and codes proteins with the same function, and 4. a sequence which can cross with the SEQ ID No. 1 in the sequence table under a highly strict condition. The coding protein is a protein which has the sequence of the amino acid residue of the SEQ ID No. 2 in the sequence table or a protein which causes the amino acid residue sequence of the SEQ ID No. 2 to have the replacement, the deletion or the adjunction of one or a plurality of amino acid residue, has the same activity as the activity of the SEQ ID No. 2, and is derived by the SEQ ID No. 2. The construction of multi-copied engineering bacteria containing the genes can effectively enhance the output of strain Nikkomycin, and has important significance for the production and the application of Nikkomycin.
Description
Technical field
The present invention relates to microbiotic biosynthetic controlling gene and proteins encoded thereof and application, the engineering bacteria that particularly relates to nikemycin biosynthetic pathway specificity regulatory gene and proteins encoded thereof and this gene of expression, and this gene and the application of engineering bacteria in nikemycin is produced.
Background technology
Nikemycin belongs to the nucleosides peptide antibiotics, is a kind of in acyl group and the glycosyl ucleosides, with the natural substrate UDP-N-acetylglucosamine similar of chitin synthetase, is the strong competitive inhibitor of this enzyme.Because chitin is fungal cell wall and insect and the ectoskeletal important composition composition of other invertebrates, therefore, nikemycin is by competitive inhibition chitinous synthetic effectively suppress fungi, insect and acarid, and nontoxic or toxicity is extremely low and easily degrade at occurring in nature to Mammals, honeybee and plant, be a kind of comparatively ideal agricultural antibiotic.Field test proof nikemycin all has good preventive and therapeutic effect to a lot of Plant diseasess as wheat powdery mildew, cucumber timberrot, leaf muld of tomato, tobacco red spot disease, apple zonate spot etc.Simultaneously, studies show that nikemycin can effectively suppress human body deep infection fungi---Candida albicans (Candida albicans), Nikemycin Z has tangible curative effect as oral pharmaceutical to coccidioidomycosis and blastomycosis.At present, increasing people is faced with the life-threatening fungi infestation that causes owing to autoimmune disease (as AIDS patient, organ transplantation patient and accept the cancer patients of chemotherapy), therefore, as the antifungal drug nikemycin huge application and potentiality to be exploited are arranged.
Studies show that antibiotic biosynthesizing relates to the biochemical reaction of a series of complexity, relevant therewith gene cluster is arranged, and their expression is subjected to multilevel multi-level regulation and control.Usually the biosynthetic regulation and control of microbiotic are mainly carried out three levels: the regulation and control of (1) approach specificity; (2) all relevant with the form differentiation with microbiotic multiple-effect is regulated and control; (3) regulation and control of overall importance.Approach specificity regulatory gene (Antibiotic-Specific Regulatory Genes) is only regulated and control certain antibiotic biosynthesizing specifically, and transcribing of they regulated and control in the general and microbiotic biosynthesis gene cluster existence of these regulatory genes.The most antibiotics biological synthesis gene cluster all comprises approach specificity regulatory gene, has plenty of one, has plenty of two or more.The streptomycete of natural generation nikemycin present known have streptomyces tendae (S.tendae) and streptomyces ansochromogenes (S.ansochromogenes).It once was that research material carries out the nikemycin related work with the streptomyces tendae that beguine university Bormann laboratory is told by Germany; And being material with the streptomyces ansochromogenes, Institute of Microorganism, Academia Sinica doctor Tan Huarong laboratory carried out the biosynthetic molecular biology research of relevant its nikemycin.Though the biosynthesizing to nikemycin has had preliminary research, still belong to blank so far to its Study of Mechanism.
Summary of the invention
The purpose of this invention is to provide a kind of nikemycin biosynthetic pathway specificity regulatory gene and proteins encoded thereof.
Nikemycin biosynthetic controlling gene provided by the present invention derives from streptomyces ansochromogenes (Streptomyces ansochromogenes), and called after sanG is one of following nucleotide sequences:
1) the SEQ ID № in the sequence table: 1;
2) SEQ ID № in the code sequence tabulation: the polynucleotide of 2 protein sequences;
3) with sequence table in SEQ ID №: 1 dna sequence dna that limits has 90% above homology, and the identical function protein DNA sequence of encoding;
4) under the rigorous degree condition of height can with the SEQ ID № in the sequence table: 1 hybridization sequence.
The rigorous degree condition of described height is meant at 68 ℃, the strict elution requirement of twice of 15 minutes wash-out among the 0.1X SSC (containing 0.1%SDS).
SEQ ID № in the sequence table: 1 dna sequence dna length is 5073bp, contain a complete open reading frame (ORP), size is 3186-bp, and initiator codon is the ATG of the 1767th beginning of this sequence 5 ' end, and terminator codon is the TGA of the 4952nd end of this sequence 5 ' end.
By the modulin SanG of this sanG genes encoding, be to have SEQ ID № in the sequence table: the protein of 2 amino acid residue sequence or with SEQ ID №: 2 amino acid residue sequence is through replacement, disappearance or the interpolation of one or several amino-acid residue and have the № with SEQ ID: 2 is identical active by SEQ ID №: 2 deutero-protein.
SEQ ID № in the sequence table: the 2nd, the protein of forming by 1061 amino-acid residues.
The application of engineering bacteria in nikemycin is produced that another object of the present invention provides the sanG gene and expresses this gene.
Contain expression carrier of the present invention and engineering bacteria and all belong to protection scope of the present invention, utilize existing molecular biological method can obtain containing the expression vector of sanG gene multiple copied, as recombinant plasmid pKC1139::sanG; And utilize expression vector to obtain engineering bacteria by conversion, as streptomyces ansochromogenes (Streptomycesansochromogenes) NK2, this bacterial strain has been preserved in China Committee for Culture Collection of Microorganisms common micro-organisms center (being called for short CGMCC) on 07 05th, 2004, preserving number is CGMCC № 1181.
Nikemycin biosynthetic pathway specificity regulatory gene sanG has been cloned in the present invention first from streptomyces ansochromogenes, and it has been carried out sequencing and analysis.Analytical results shows, the product of this coded by said gene and multiple microbiotic biosynthetic controlling albumen (SARPs) have certain homology, but its coded albumen (containing 1061 amino-acid residues) is big more a lot of than general microbiotic biosynthetic controlling albumen (containing 200-400 amino-acid residue), is the new microbiotic modulin of a class.Show that by gene functional research sanG destroys strain and lost the generation ability of nikemycin, and the sanG gene of introducing a copy again can make nikemycin produce again, shows that this gene is a positive regulating gene.The inventor imports the sanG gene of a plurality of copies in the streptomyces ansochromogenes wild strain simultaneously, makes up and has obtained a strain nikemycin high yield engineering bacteria, can make nikemycin output improve 2-3 doubly.The research of gene of the present invention, development and application are extremely important to the production application of nikemycin.
Description of drawings
Fig. 1 is the design of graphics of sanG gene high expression carrier pKC1139::sanG;
Fig. 2 is that the activity of engineering strain nikemycin detects photo;
Fig. 3 is the production curve of engineering strain nikemycin;
Fig. 4 is the HPLC analysis of spectra of engineering strain nikemycin;
Fig. 5 is the physics spectrogram of plasmid pUC119::kmr;
Fig. 6 is the physics spectrogram of plasmid pGL001.
Embodiment
The clone of embodiment 1, sanG gene and sequential analysis
1, the preparation of clone's probe
Utilize XhoI-BamHI digested plasmid pZH1300 (Li, W., and Tan, H.Structure and functionof sanV:a gene involved in nikkomycin biosynthesis of Streptomycesansochromogenes.Curr.Microbiol.2003.46 (6): 403-407.), carry out polyacrylamide gel electrophoresis according to a conventional method, reclaim the dna fragmentation (this fragment contains part sanV gene) of 1.7kb then with the DEAE embrane method; The reclaim dna fragmentation that obtains is carried out the on-radiation digoxigenin labeled according to a conventional method, and as the probe of gene clone, the nucleotides sequence of this probe is classified the SEQ ID № in the sequence table as: 3.
2, make up portion gene group library
Inoculation streptomyces ansochromogenes 7100 (Tan Huarong, Wu Wei, Tian Yuqing etc.Streptomyces ansochromogenes differentiation and characteristic research thereof.The microorganism journal, 1994,34:398-402) spore suspension is in the YEME liquid nutrient medium, shaking table was cultivated 48 hours, centrifugal collection thalline, and extract with ordinary method and to obtain the total DNA (Kieser of streptomyces ansochromogenes, T., Bibb, M.J., Buttner, M.J., Chater, K.F., and Hopwood, D.A. (2000) PracticalStreptomyces Genetics.Norwich:The John lnnes Foundation.).
The total DNA of digestion with restriction enzyme streptomyces ansochromogenes with different carries out agarose gel electrophoresis, carries out Southern hybridization with above-mentioned clone's probe then, and wherein the XhoI enzyme is cut the signal band that product obtains a 7.5kb.Cut the total DNA of streptomyces ansochromogenes with a large amount of enzymes of XhoI, carry out agarose gel electrophoresis, reclaim the dna fragmentation of size about 7.5kb, get partially recycled dna fragmentation and carry out Southern hybridization once more, the result shows among the DNA that is reclaimed and contains target DNA.
The pBluescriptII carrier (available from Stratagene company, the U.S.) that the DNA and the XhoI enzyme of recovery are cut connects according to a conventional method, adopts electrotransformation Transformed E .coli DH5a then, is built into portion gene group library.
3, the clone of sanV gene downstream 7.5kb dna fragmentation
XhoI-BamHI dna fragmentation with the resulting 1.7kb of step 1 is probe (the SEQ ID № in the sequence table: 3), adopt colony hybridization method that the portion gene library of streptomyces ansochromogenes 7100 is screened, wherein 1 recombinant plasmid obtains positive signal, called after pGL001.This carrier enzyme is cut the result and is shown, wherein contains the XhoI dna fragmentation of the 7.5kb that comprises part sanV gene.
4, sanG Gene Sequence Analysis
Dna sequencing method is routinely carried out sequencing to the 7.5kb dna fragmentation, and it does not comprise that the nucleotides sequence of part sanV gene classifies the SEQ ID № in the sequence table as: 1, and length is 5073bp.With FramePlot software this sequence is analyzed, the result shows that G+C% is about 72.2% in the whole nucleotide sequence, has typical streptomycete codon use characteristic, wherein contain a complete open reading frame (ORP), size is 3186-bp, initiator codon is the ATG of the 1767th beginning of this sequence 5 ' end, and terminator codon is the TGA of the 4952nd end of this sequence 5 ' end, with its called after sanG.
The sanG protein of being made up of 1061 amino-acid residues (SanG) of encoding, its amino acid residue sequence is the SEQ ID № in the sequence table: 2.In the protein sequence database of NCBI, carry out homology relatively, the result shows that the microbiotic biosynthetic controlling albumen (SARPs) of Protein S anG and streptomycete has higher homology, but this albumen (containing 1061 amino-acid residues) is big more a lot of than general microbiotic biosynthetic controlling albumen (containing 200-400 amino-acid residue), also have a typical helix turn helix (helix-turn-helix at its aminoterminal, HTH) DNA is the novel microbiotic modulin of a class in conjunction with territory (from 258 Leu of the 99th Arg to the of N end).
The functional study of embodiment 2, sanG gene
1, makes up the recombinant plasmid pGLD020 that is used for gene disruption
With XhoI digested plasmid pGL001, reclaim the dna fragmentation of 7.5-kb size, subclone makes up and obtains recombinant plasmid pGLD021 to the salI site of the pUC19 that has deleted the BamHI site.Cut pGLD021 with the BamHI enzyme, mend flat end with Klenow then, reclaim the fragment of this 6-kb size; Use BamHI and EcoRI double digestion recombinant plasmid pUC119::kmr (physics spectrogram such as Fig. 5 of this plasmid) simultaneously, mend flat end, reclaim the kalamycin resistance gene fragment of about 1.0-kb through Klenow; Connect above two dna fragmentations, will connect product Transformed E .coli DH5 α, extract plasmid from transformant, enzyme obtains correct recombinant plasmid pGLD022 after cutting checking.Further use HindIII and EcoRI double digestion pGLD022, reclaim the dna fragmentation of 4.4-kb and be cloned into pKC1139 (Kieser, T., Bibb, M.J., Buttner, M.J., Chater, K.F., and Hopwood, D.A. (2000) PracticalStreptomyces Genetics.Norwich:The John lnnes Foundation.) on the multiple clone site, makes up the recombinant plasmid pGLD020 that obtains being used for gene disruption.Operations such as above enzyme is cut, reclaims, cloned, conversion are all carried out according to the experimental methods of molecular biology of routine.
2, make up the sanG blocked mutant
At first plasmid pGLD020 is transferred among the E.coli ET12567, cultivate, extract the non-methylated DNA of acquisition, transform the protoplastis of streptomyces ansochromogenes 7100 then with this DNA, random choose wherein 6 transformants is forwarded to enrichment thalline among the YEME that contains apramycin (Apramycin), cut checking through plasmid extraction, enzyme, prove that the gained transformant all is correct.One of them transformant is forwarded on the minimum medium flat board that contains apramycin, cultivates after 7 days the preparation spore suspension for 28 ℃.After suitably diluting, with each plate 10
4The concentration of individual spore is coated on the minimum medium flat board that contains kantlex, in 42 ℃ of high-temperature cultivation.PKC1139 has the responsive to temperature type replication orgin, in that be higher than can not normal replication under 34 ℃ of conditions.Therefore, being that the carrier pGLD020 of fundamental construction can not self-replicating in the time of 42 ℃ with pKC1139, having only when homologous recombination has taken place for sanG gene and flanking sequence thereof and streptomyces ansochromogenes 7100 karyomit(e)s---single cross is changed or the bacterial strain of double exchange could be grown containing on the minimum medium of kantlex.If double exchange has taken place, then kmr replaces the sanG gene, and this moment, bacterium colony showed as Km
rAm
sIf single cross has taken place changes, then whole pGLD020 is inserted on the karyomit(e), and this moment, bacterium colony showed as Km
rAm
rThe bacterium colony that grows xeroxed respectively containing Apramycin and containing on the MM flat board of Kanamycin, those are grown containing on the MM flat board of Kanamycin, and are that double exchange may take place for homologous gene on the karyomit(e) containing the bacterium colony of not growing on the MM flat board of Apramycin.6 plant mutant strains of random screening are seeded on the minimum medium without any selective pressure, cultivate down at 28 ℃, be forwarded to again on the minimum medium that contains kantlex and apramycin respectively after passing for 5 generations, the result still shows as Km
rAm
s, illustrate that these sanG deletion mutantion strains that obtain by double exchange are stable in heredity.
3, the Southern blotting of blocked mutant hybridization checking
Stable blocked mutant in the above-mentioned 6 strain heredity is inoculated in the YEME substratum, 28 ℃, the 250rpm shaking culture is extracted total DNA respectively after 30 hours, cut laggard row agarose gel electrophoresis with the XhoI enzyme, reclaim the dna fragmentation of 7.5kb, then dna fragmentation is carried out digoxigenin labeled.
Dna fragmentation with the 7.5kb of digoxigenin labeled is that probe carries out Southern blot hybridization, take place the positive signal band that total DNA presented of the mutant strain of double exchange should little 3.2kb than wild type strain about, theoretically infer that size is respectively 4.3-kb and 7.5-kb.Results of hybridization proves that the hybridization signal band of mutant strain is consistent with the molecular weight size of calculating in theory, illustrates that resulting mutant strain all is correct.
4, nikemycin biological detection and HPLC analyze
Correct blocked mutant and the wild type strain of Southern blotting hybridization checking is seeded in respectively in the YEME substratum, behind 30 ℃ of cultivation 36h, inoculum size with 1% is carried out Secondary Fermentation in the SP substratum, take a sample respectively at different incubation times, detect the rough content of nikemycin in thalline weight in wet base and the supernatant.Behind the filtering with microporous membrane of supernatant liquor through diameter 0.25 μ m, carry out HPLC according to a conventional method and analyze, showing does not have nikemycin in the supernatant, and surveys the thalline weight in wet base and wild type strain does not almost have difference at each time point.The result shows that sanG deletion mutantion strain no longer produces nikemycin, illustrates that the sanG gene is that the nikemycin biosynthesizing is necessary.
5, the complementation analysis of sanG deletion mutantion strain
For the phenotype of getting rid of sanG deletion mutantion strain is because this possibility that other gene point mutation caused on the karyomit(e) has been carried out the genetic complementation experiment of mutant strain.With BamHI digested plasmid pGL001, reclaim the dna fragmentation of 3.3-kb, be connected (Bierman with pSET152, M., Logan, R., O ' Brien, K., Seno, E.T., Rao, R.N., and Schoner, B.E.Plasmid cloning vectors for the conjugal transfer of DNA fromEscherichia coli to Streptomyces spp.Gene.1992.116:43-49), uses Bg1II and EcoRI double digestion then, reclaim big fragment wherein; With BglII and EcoRI double digestion pGL001, reclaim the dna fragmentation of 4.1kb, two segment DNA fragments are connected, be built into the recombinant plasmid pSET152::sanG that contains complete sanG gene and upstream promoter thereof.
Changing pSET152::sanG over to E.coli ET12567/pUZ8002, cultivate, extract the pSET152::sanG that obtains removing restriction modification, change over to then among the deletion mutantion strain, is selection markers screening transformant with the apramycin.Random screening 6 strain transformants ferment in the SP substratum, carry out the nikemycin biological activity assay then, the result shows that the mutant strain behind the sanG gene complementation has recovered the generation ability of nikemycin, illustrates that from another point of view the sanG gene is that the nikemycin biosynthesizing is necessary.
The structure of embodiment 3, nikemycin high-yielding engineering bacterial strain
1, the structure of the high copy of sanG gene recombinant plasmid pKC1139::sanG
The process of structure sanG gene high expression carrier pKC1139::sanG as shown in Figure 1.With XhoI digested plasmid pGL001 (physics spectrogram such as Fig. 6 of this plasmid), reclaim the dna fragmentation of 7.5-kb, this dna fragmentation contains complete sanG gene and promoter sequence thereof, this fragment is inserted the SalI site of vector plasmid pUC19, the plasmid that obtains is carried out double digestion with HindIII and EcoRI, reclaim the HindIII-EcoRI fragment of 7.5-kb; The dna fragmentation of gained is inserted into the multiple clone site of the multiple copied plasmid pKC1139 that can shuttle back and forth in E.coli and streptomycete, makes up and obtain the high copy of sanG gene recombinant plasmid pKC1139::sanG.
2, transform, screen the nikemycin high-yielding engineering bacterial strain
Change pKC1139::sanG over to E.coli ET12567/pUZ8002, cultivate, extract the pKC1139::sanG that obtains removing restriction modification, pKC1139::sanG is changed in the wild type strain streptomyces ansochromogenes 7100 then, with the apramycin is selection markers screening transformant, obtains the nikemycin engineering bacteria.
Therefrom screening 3 strain engineering bacterias ferments in the SP substratum, carry out the nikemycin biological activity assay then, and compare with wild type strain 7100, the result as shown in Figure 2, B, C, D are engineering bacteria among the figure, 7100 is streptomyces ansochromogenes 7100, and 7100/pKC1139 is the control strain that contains empty carrier pKC1139.The result shows that the generation ability of 3 strain engineering bacteria nikemycins all is higher than wild type strain 7100.
Detect the output of engineering bacteria nikemycin with HPLC, and be contrast with streptomyces ansochromogenes 7100, the result as shown in Figure 3, Figure 4, B, C, D are engineering bacteria among Fig. 3,7100 is streptomyces ansochromogenes 7100, and 7100/pKC1139 is the control strain that contains empty carrier pKC1139; Fig. 4 A is engineering bacteria streptomyces ansochromogenes (Streptomycesansochromogenes) NK2 CGMCC № 1181 culture HPLC collection of illustrative plates, B is streptomyces ansochromogenes 7100 culture HPLC collection of illustrative plates (the X peak is a nikemycin X component in the HPLC spectrogram, and the Z peak is a Nikemycin Z component).The result shows that the nikemycin output of engineering bacteria significantly improves, for the 2-3 of wild strain doubly.
Sequence table
<160>3
<210>1
<211>5073
<212>DNA
<213〉streptomyces ansochromogenes (Streptomyces ansochromogenes)
<400>1
ggatcctttg?cctccccgac?ggcacctgat?cgagcgggtg?ccgtgcgtgc?ggctgcgggt 60
cacgcgtccg?gttcggctcc?ggtcatcagg?gcgagcaggg?gtgtaagggg?cgtggtcgtc 120
gatcatggtg?gtgtagaagc?cgtcgtcgtc?cgcttccacc?tcggcggcgc?gggagaacgt 180
cacctgttcg?tgcgaggcga?gcgcggcttc?ggtgtcgccg?gggtgcgtgg?cgagggcgcg 240
gccgagtccg?gcgccgtccg?gcatggccgg?gttggcgccc?ttgccgttcg?gtgcccgcag 300
gcgggcggcg?tccccgagca?gcgtcacccc?ggccacgcga?cgcctcaccg?cctaccgtgc 360
acgaactcgc?cagggccggc?cgggccggct?tttacgcctg?caacgctccc?gaagggcagt 420
cggacctccg?aaaccgacaa?tatccacatt?tgttctgttt?tgttcttcct?ggtgcgtcaa 480
cctcatcccg?aatggccagg?tcgcggatac?atggagccac?tttaagtcac?ctggctcatt 540
cgcgttcgcc?cagctcagga?gaatgctcga?tacactgatt?ccggcgaggc?ataccagcct 600
cagaaaagca?ggggcatcgc?gaacaccatg?aacgcaaaca?tgtccgagcg?gaatggaaac 660
atcagccgac?tcaccacagc?cgacccgacc?gtccgtgccg?cagaccgcac?ccatttcccc 720
cctcccaccc?ccgaggggaa?gaggacacgc?aaggcaacca?cgacacaaca?ggaacccagg 780
ccgtccgggc?cctccgtacc?cgcccagaac?caggccgccg?caccggacgc?caccttcacg 840
accgcgcccg?tccccctctc?acgcggcaca?gcagtccgga?tacgacctcg?cggggcccgg 900
caagcccggc?cggccgggac?gcgctccgag?accgtgacga?aaggcgaccc?ctggggaggg 960
tgggctgtgc?gccagcggca?cagggctgag?gcgaccgctc?tcaggcaggc?agcgaggtca 1020
ctggctgaat?accaggcgct?ggcaagaaga?ggcactcgac?tatcaggcga?gacggcgtaa 1080
tggccggcag?ccgcaggggc?cgctggggcc?tccttgtcgc?gatgcggttc?ggcgtcggca 1140
atggctggta?ttggctgtgc?tcgggtgcgg?acgttgacac?gttaatcgtt?tccggcaatt 1200
ccgatttggc?caatcggcgt?ttgcgagccg?ggttgccgcc?gctccaggcg?gcagtagacg 1260
gcctttcggc?catttcagct?catgagctga?tcgagcggct?cgtcgcccat?ggccgcgttc 1320
ggatcaccca?cgctgatgat?gacgaggtcg?cggagtcccg?gcgcgtcgtc?gaccacgcga 1380
aacggcacgg?cctgagacca?gcgggcaagc?gcattgagaa?agttccgtac?ggcgggtcgg 1440
ggctggagct?cgtcataggg?ggttgttccg?gtcgccgcgg?gccggccgga?agcagaaccg 1500
ggcggcccgg?gtgttccgcg?agcccgggct?ccgcgcgcat?caggccgttc?ctgccctccg 1560
cgcccgccgg?tccctccggc?cggcacagcc?gcgcccctcc?tgaacgcggg?accggacgag 1620
cgggcacggc?cagctcactg?gccggtatcg?aaatcgccgt?gtcatggcgt?gttcagtgcg 1680
tcacttgatc?ggcaccgttt?cagcacctgc?cccgccctac?gaccgaccgc?ccgtcaagtg 1740
accgtcgaaa?ggcaagaacc?cccggcatgg?cgtacacagc?tcaagagcaa?caaaccgcgt 1800
ccctgacaga?tctgtcgttc?gaggctttcg?gtgtgatgac?ggctcggcgc?ggggccgagc 1860
aggtgcctct?cggtccccca?cggcaccggg?ccgtgctggg?actgctgctc?atccggctgg 1920
gccaagtggt?gcccgccgat?cagctcatcg?acgaattatg?gggcgacagc?ctccccagac 1980
gcccgcagcc?accctgcaga?acgtacctgt?cccacctgcg?gcgggtgctg?acggggcggc 2040
acgggccgat?cgccccgctg?cgctaccagg?cccccgggta?cgtcctgacg?gtggagccgg 2100
gcacgttcga?cctgtcccgg?ttcgagaccc?tcgtctccca?ggggcagcgc?catgtgtccg 2160
acggccggct?ccaggacgcc?cgcgacgcgt?tcgacaacgc?gctgcggtta?tggcgggcgg 2220
accccttcct?ggacctcgcg?gcctacaccc?cgctcgcgga?ggaggccgcc?cgcctgagcc 2280
tcctgcggac?caccgccgtc?gcggcccaag?ccgacacgct?cctcacgctc?ggcgaggcct 2340
gcgacgccgt?cgcgctgctg?cgccgcgagg?tgtccctcca?gcccatcgac?gaacgcctgg 2400
tcggcagcct?catgacgggc?ctgtaccgcc?tgggccggca?ggccgaggcg?ctccagctgt 2460
acgaccggac?gcgcgcctac?ctctccgagg?agctcggggt?cgccccggcc?cgcgagctcc 2520
agcgcgtcca?cctcgccctg?ctgcgccacg?aactcgacga?ccagacgtcc?gccccggccg 2580
ccgtcgaggt?acgcgtccgg?cccggcaccg?tggccgagcg?ggaggcggag?gggcccgcgc 2640
cggcagacgg?tccggaggcc?gtccccgagg?ccggacagcg?gggtacggca?ccggcggcct 2700
ggttcccctg?ccgcggcgac?gcccttgacg?ctctgcggtc?gtccatcacc?ggcgccctgc 2760
gcggcagcgg?gcacaccacc?gccgtcgtcg?gcgaggcggg?cgtcggcaag?accgaactgg 2820
tggcccgtgc?cacggatcag?acgcagccgc?cgcaaccgca?ggcggaggtc?atccgtgtca 2880
actgccgcag?cgacgagggg?attcccgtcg?gctgggtgtg?gcagcaggtg?ctgcgccggc 2940
tcgacatcct?gttcggggag?tccttcgacg?acctgcgcaa?gcagcgcgcc?gaagggcatc 3000
cggtgacaac?gctgtcggaa?cccccctcgg?accagatgga?cttcctcgcc?caggacgccc 3060
tgtgcgaagt?gatcctccag?tacgccgacg?gcaggcccct?cctgctcgtc?ctcgaagaca 3120
gtgcaccggc?ggaccgcctc?acgctcgacg?tgctggggct?gttctgcagc?cgcacgcagg 3180
ggcggcccgt?cagcgtggtg?atcacggtcc?gcgaacccgg?tctcggggcc?gggcccgaga 3240
ccgacggccc?gctcgtcgac?ctcctggccg?actcccgcac?caaggtcgtg?cacctggaca 3300
acctcaccga?ggactacgtc?cgggccgcgg?tcacggccca?ggcggggccc?ggcgtcgaag 3360
cgtccgtcgt?acgggcgctg?tacgagcgca?gcgccggcaa?cccctatctc?ctcgaccagt 3420
tgatcgccga?cgccggcggg?gcgcggcgcc?tgcacgatcc?ccgtgcggcc?gatgtcgtcc 3480
gcgccgggat?cccgacgggc?gtccgcagca?tgctgcgccg?gcagttcgcc?gggctgcccc 3540
cgcgcgtcct?gcacctcctc?cagtgctgcg?ccgtgctcgg?cggcgaggcg?acgctggcct 3600
cgctgaccgc?catgctggac?gacgaaggcg?ccggccacga?cgtcctggaa?gaggtcctgg 3660
cgaccgggct?catgcacagc?gaccgcgacg?acccgcaccg?gctcgtcttc?cgctacggcc 3720
tcatccgcga?cgtcctcctg?gcggagctgc?gccgccagga?gcgggcggcc?ctgcacgcgc 3780
gcgccgtcgg?cgtgctcggt?gcccgccacg?gcgactcccc?cgaggcgagc?gagcagatcg 3840
ccgagcacgc?ctggcaggcc?gtgctggccc?tgccggccga?ggacgtgctg?ccgcacctca 3900
gacgcgccgg?cgaacaggcc?gtcgtcgagg?gcgactaccg?gcgcgcgcag?acctggttcg 3960
agcacgcgca?caccttgctc?tgcgccctgc?cccgggacgg?tggcgcgcca?tcgaagcaga 4020
cgctggacct?gcgcagcaag?ctcctctaca?cggcgagcat?cacccgcggc?tacaccaacc 4080
gggaaggtga?aggccgaggc?cgggcgcatc?ccggaagctg?tacgccgcca?cgggcgggcc 4140
ggaccatcga?gcagggtgcc?ttgctgctgt?ggcagttcgt?ggccgaactg?gtcaccgccc 4200
ggcacaccga?gtgcgcccgg?cacgcggagc?agctgcgcgc?tctcaccgag?cggtccgacg 4260
ccccggaggt?ccggttctac?gagcggatcg?cccgcggtct?gctccagttg?cccagcgatg 4320
ccgccgacgc?gctcaccgcc?ctgaccgagg?cggtgcggat?cgccgagaag?ctgacccccg 4380
cacagcggga?gcgcatgacg?cgccgcgccc?agcaggatcc?gcggttcatg?gccgcgaacc 4440
atcgcgtcct?caccctgagg?ctgctcggcg?ccaccgacga?ggcgcgggcg?ctgtgcgagg 4500
agctgctggt?agccaccggc?ctggacggca?cgccggtcga?ccaggcgagc?gcgtactact 4560
tccactccct?gacagcggcc?ctgggcgagg?accccgacgg?ggcggcggcc?tccagcggcc 4620
ggggcctgga?catcgcccgc?gcccacgggc?tgagccactg?gaccgccatg?ctccaggtgt 4680
gccggagctg?ggcactccac?cagagcggcg?aggccgccgc?actcgacagc?ctggaatcgg 4740
ccgtcgccga?gctgcgcgag?cggcggctgc?tcatccggct?gccgctccac?ctgggcctgc 4800
tggcccacgc?ccagcacagc?agcggggcgg?ccgaagacgc?cagacggacg?ctgcggtcgt 4860
cgaccgcgga?ggccagatcc?cgcggggagt?tggcctatgt?gagccgcact?ctgccgttca 4920
cccggctgtg?tcccctgacg?tccgcttcgt?agcggccgga?tcgtcggttc?cttcgcctct 4980
cagccgggcg?cgggcctggc?cggcctcggg?gtggccgagt?ccgtcgaggg?tccgcgccgc 5040
ctcccgccac?agggcagggc?ggcggggcgg?tct 5073
<210>2
<211>1061
<212>PRT
<213〉streptomyces ansochromogenes (Streptomyces ansochromogenes)
<400>2
Met?Ala?Tyr?Thr?Ala?Gln?Glu?Gln?Gln?Thr?Ala?Ser?Leu?Thr?Asp?Leu
1 5 10 15
Ser?Phe?Glu?Ala?Phe?Gly?Val?Met?Thr?Ala?Arg?Arg?Gly?Ala?Glu?Gln
20 25 30
Val?Pro?Leu?Gly?Pro?Pro?Arg?His?Arg?Ala?Val?Leu?Gly?Leu?Leu?Leu
35 40 45
Ile?Arg?Leu?Gly?Gln?Val?Val?Pro?Ala?Asp?Gln?Leu?Ile?Asp?Glu?Leu
50 55 60
Trp?Gly?Asp?Ser?Leu?Pro?Arg?Arg?Pro?Gln?Pro?Pro?Cys?Arg?Thr?Tyr
65 70 75 80
Leu?Ser?His?Leu?Arg?Arg?Val?Leu?Thr?Gly?Arg?His?Gly?Pro?Ile?Ala
85 90 95
Pro?Leu?Arg?Tyr?Gln?Ala?Pro?Gly?Tyr?Val?Leu?Thr?Val?Glu?Pro?Gly
100 105 110
Thr?Phe?Asp?Leu?Ser?Arg?Phe?Glu?Thr?Leu?Val?Ser?Gln?Gly?Gln?Arg
115 120 125
His?Val?Ser?Asp?Gly?Arg?Leu?Gln?Asp?Ala?Arg?Asp?Ala?Phe?Asp?Asn
130 135 140
Ala?Leu?Arg?Leu?Trp?Arg?Ala?Asp?Pro?Phe?Leu?Asp?Leu?Ala?Ala?Tyr
145 150 155 160
Thr?Pro?Leu?Ala?Glu?Glu?Ala?Ala?Arg?Leu?Ser?Leu?Leu?Arg?Thr?Thr
165 170 175
Ala?Val?Ala?Ala?Gln?Ala?Asp?Thr?Leu?Leu?Thr?Leu?Gly?Glu?Ala?Cys
180 185 190
Asp?Ala?Val?Ala?Leu?Leu?Arg?Arg?Glu?Val?Ser?Leu?Gln?Pro?Ile?Asp
195 200 205
Glu?Arg?Leu?Val?Gly?Ser?Leu?Met?Thr?Gly?Leu?Tyr?Arg?Leu?Gly?Arg
210 215 220
Gln?Ala?Glu?Ala?Leu?Gln?Leu?Tyr?Asp?Arg?Thr?Arg?Ala?Tyr?Leu?Ser
225 230 235 240
Glu?Glu?Leu?Gly?Val?Ala?Pro?Ala?Arg?Glu?Leu?Gln?Arg?Val?His?Leu
245 250 255
Ala?Leu?Leu?Arg?His?Glu?Leu?Asp?Asp?Gln?Thr?Ser?Ala?Pro?Ala?Ala
260 265 270
Val?Glu?Val?Arg?Val?Arg?Pro?Gly?Thr?Val?Ala?Glu?Arg?Glu?Ala?Glu
275 280 285
Gly?Pro?Ala?Pro?Ala?Asp?Gly?Pro?Glu?Ala?Val?Pro?Glu?Ala?Gly?Gln
290 295 300
Arg?Gly?Thr?Ala?Pro?Ala?Ala?Trp?Phe?Pro?Cys?Arg?Gly?Asp?Ala?Leu
305 310 315 320
Asp?Ala?Leu?Arg?Ser?Ser?Ile?Thr?Gly?Ala?Leu?Arg?Gly?Ser?Gly?His
325 330 335
Thr?Thr?Ala?Val?Val?Gly?Glu?Ala?Gly?Val?Gly?Lys?Thr?Glu?Leu?Val
340 345 350
Ala?Arg?Ala?Thr?Asp?Gln?Thr?Gln?Pro?Pro?Gln?Pro?Gln?Ala?Glu?Val
355 360 365
Ile?Arg?Val?Asn?Cys?Arg?Ser?Asp?Glu?Gly?Ile?Pro?Val?Gly?Trp?Val
370 375 380
Trp?Gln?Gln?Val?Leu?Arg?Arg?Leu?Asp?Ile?Leu?Phe?Gly?Glu?Ser?Phe
385 390 395 400
Asp?Asp?Leu?Arg?Lys?Gln?Arg?Ala?Glu?Gly?His?Pro?Val?Thr?Thr?Leu
405 410 415
Ser?Glu?Pro?Pro?Ser?Asp?Gln?Met?Asp?Phe?Leu?Ala?Gln?Asp?Ala?Leu
420 425 430
Cys?Glu?Val?Ile?Leu?Gln?Tyr?Ala?Asp?Gly?Arg?Pro?Leu?Leu?Leu?Val
435 440 445
Leu?Glu?Asp?Ser?Ala?Pro?Ala?Asp?Arg?Leu?Thr?Leu?Asp?Val?Leu?Gly
450 455 460
Leu?Phe?Cys?Ser?Arg?Thr?Gln?Gly?Arg?Pro?Val?Ser?Val?Val?Ile?Thr
465 470 475 480
Val?Arg?Glu?Pro?Gly?Leu?Gly?Ala?Gly?Pro?Glu?Thr?Asp?Gly?Pro?Leu
485 490 495
Val?Asp?Leu?Leu?Ala?Asp?Ser?Arg?Thr?Lys?Val?Val?His?Leu?Asp?Asn
500 505 510
Leu?Thr?Glu?Asp?Tyr?Val?Arg?Ala?Ala?Val?Thr?Ala?Gln?Ala?Gly?Pro
515 520 525
Gly?Val?Glu?Ala?Ser?Val?Val?Arg?Ala?Leu?Tyr?Glu?Arg?Ser?Ala?Gly
530 535 540
Asn?Pro?Tyr?Leu?Leu?Asp?Gln?Leu?Ile?Ala?Asp?Ala?Gly?Gly?Ala?Arg
545 550 555 560
Arg?Leu?His?Asp?Pro?Arg?Ala?Ala?Asp?Val?Val?Arg?Ala?Gly?Ile?Pro
565 570 575
Thr?Gly?Val?Arg?Ser?Met?Leu?Arg?Arg?Gln?Phe?Ala?Gly?Leu?Pro?Pro
580 585 590
Arg?Val?Leu?His?Leu?Leu?Gln?Cys?Cys?Ala?Val?Leu?Gly?Gly?Glu?Ala
595 600 605
Thr?Leu?Ala?Ser?Leu?Thr?Ala?Met?Leu?Asp?Asp?Glu?Gly?Ala?Gly?His
610 615 620
Asp?Val?Leu?Glu?Glu?Val?Leu?Ala?Thr?Gly?Leu?Met?His?Ser?Asp?Arg
625 630 635 640
Asp?Asp?Pro?His?Arg?Leu?Val?Phe?Arg?Tyr?Gly?Leu?Ile?Arg?Asp?Val
645 650 655
Leu?Leu?Ala?Glu?Leu?Arg?Arg?Gln?Glu?Arg?Ala?Ala?Leu?His?Ala?Arg
660 665 670
Ala?Val?Gly?Val?Leu?Gly?Ala?Arg?His?Gly?Asp?Ser?Pro?Glu?Ala?Ser
675 680 685
Glu?Gln?Ile?Ala?Glu?His?Ala?Trp?Gln?Ala?Val?Leu?Ala?Leu?Pro?Ala
690 695 700
Glu?Asp?Val?Leu?Pro?His?Leu?Arg?Arg?Ala?Gly?Glu?Gln?Ala?Val?Val
705 710 715 720
Glu?Gly?Asp?Tyr?Arg?Arg?Ala?Gln?Thr?Trp?Phe?Glu?His?Ala?His?Thr
725 730 735
Leu?Leu?Cys?Ala?Leu?Pro?Arg?Asp?Gly?Gly?Ala?Pro?Ser?Lys?Gln?Thr
740 745 750
Leu?Asp?Leu?Arg?Ser?Lys?Leu?Leu?Tyr?Thr?Ala?Ser?Ile?Thr?Arg?Gly
755 760 765
Tyr?Thr?Asn?Arg?Glu?Gly?Glu?Gly?Arg?Gly?Arg?Ala?His?Pro?Gly?Ser
770 775 780
Cys?Thr?Pro?Pro?Arg?Ala?Gly?Arg?Thr?Ile?Glu?Gln?Gly?Ala?Leu?Leu
785 790 795 800
Leu?Trp?Gln?Phe?Val?Ala?Glu?Leu?Val?Thr?Ala?Arg?His?Thr?Glu?Cys
805 810 815
Ala?Arg?His?Ala?Glu?Gln?Leu?Arg?Ala?Leu?Thr?Glu?Arg?Ser?Asp?Ala
820 825 830
Pro?Glu?Val?Arg?Phe?Tyr?Glu?Arg?Ile?Ala?Arg?Gly?Leu?Leu?Gln?Leu
835 840 845
Pro?Ser?Asp?Ala?Ala?Asp?Ala?Leu?Thr?Ala?Leu?Thr?Glu?Ala?Val?Arg
850 855 860
Ile?Ala?Glu?Lys?Leu?Thr?Pro?Ala?Gln?Arg?Glu?Arg?Met?Thr?Arg?Arg
865 870 875 880
Ala?Gln?Gln?Asp?Pro?Arg?Phe?Met?Ala?Ala?Asn?His?Arg?Val?Leu?Thr
885 890 895
Leu?Arg?Leu?Leu?Gly?Ala?Thr?Asp?Glu?Ala?Arg?Ala?Leu?Cys?Glu?Glu
900 905 910
Leu?Leu?Val?Ala?Thr?Gly?Leu?Asp?Gly?Thr?Pro?Val?Asp?Gln?Ala?Ser
915 920 925
Ala?Tyr?Tyr?Phe?His?Ser?Leu?Thr?Ala?Ala?Leu?Gly?Glu?Asp?Pro?Asp
930 935 940
Gly?Ala?Ala?Ala?Ser?Ser?Gly?Arg?Gly?Leu?Asp?Ile?Ala?Arg?Ala?His
945 950 955 960
Gly?Leu?Ser?His?Trp?Thr?Ala?Met?Leu?Gln?Val?Cys?Arg?Ser?Trp?Ala
965 970 975
Leu?His?Gln?Ser?Gly?Glu?Ala?Ala?Ala?Leu?Asp?Ser?Leu?Glu?Ser?Ala
980 985 990
Val?Ala?Glu?Leu?Arg?Glu?Arg?Arg Leu?Leu?Ile?Arg?Leu Pro?Leu?His
995 1000 1005
Leu?Gly Leu?Leu?Ala?His?Ala Gln?His?Ser?Ser?Gly Ala?Ala?Glu
1010 1015 1020
Asp?Ala?Arg?Arg?Thr?Leu?Arg?Ser?Ser?Thr?Ala?Glu?Ala?Arg?Ser
1025 1030 1035
Arg?Gly?Glu?Leu?Ala?Tyr?Val?Ser?Arg?Thr?Leu?Pro?Phe?Thr?Arg
1040 1045 1050
Leu?Cys?Pro?Leu?Thr?Ser?Ala?Ser
1055 1060
<210>3
<211>1691
<212>DNA
<213〉streptomyces ansochromogenes (Streptomyces ansochromogenes)
<400>3
ggatccgcgg?ttcatggccg?cgaaccatcg?cgtcctcacc?ctgaggctgc?tcggcgccac 60
cgacgaggcg?cgggcgctgt?gcgaggagct?gctggtagcc?accggcctgg?acggcacgcc 120
ggtcgaccag?gcgagcgcgt?actacttcca?ctccctgaca?gcggccctgg?gcgaggaccc 180
cgacggggcg?gcggcctcca?gcggccgggg?cctggacatc?gcccgcgccc?acgggctgag 240
ccactggacc?gccatgctcc?aggtgtgccg?gagctgggca?ctccaccaga?gcggcgaggc 300
cgccgcactc?gacagcctgg?aatcggccgt?cgccgagctg?cgcgagcggc?ggctgctcat 360
ccggctgccg?ctccacctgg?gcctgctggc?ccacgcccag?cacagcagcg?gggcggccga 420
agacgccaga?cggacgctgc?ggtcgtcgac?cgcggaggcc?agatcccgcg?gggagttggc 480
ctatgtgagc?cgcactctgc?cgttcacccg?gctgtgtccc?ctgacgtccg?cttcgtagcg 540
gccggatcgt?cggttccttc?gcctctcagc?cgggcgcggg?cctggccggc?ctcggggtgg 600
ccgagtccgt?cgagggtccg?cgccgcctcc?cgccacaggg?cagggcggcg?gggcggtctc 660
cccgggactc?gtgggtgtct?cccatgtgat?ggacccagcg?ggtactgcgt?gctcctccgg 720
ggcagcagcg?gcaggaccgg?gaagggtgtg?ccgggcgccg?gcatcaggtc?ggcgccctca 780
cgcagggcgg?ccaggtgttc?gctgtcgacg?gcggaaaaca?gggggtgcac?ccggattacc 840
gggggactcc?ccgcgctgct?tctccgcgcc?ggagggagag?ggcctgggcg?tagagctcgg 900
cggcggcgca?ccggcagggc?ccccgggggc?ggagcgggga?gtcgggcttc?agcggtttcc 960
gcaaggagcc?gatgtggcgg?tggacgacgt?ccacggtgct?gttcggcggg?tcgccgtgcc 1020
acaggacgtc?gacgatctgg?ctcaggccga?cggtctgtcc?ggcgtgcaac?ggcaacgccg 1080
gcaaggcgcg?ctgcttcggt?ggtccgaggg?cgactcggcg?cctgaccgcc?acactgcgac 1140
cggccccagg?accatggtgg?tcctggtgtt?cgtgatcttc?ctcgccgtgc?ggcccgtcaa 1200
cgagggtggc?tggtccggga?cgggtggtcg?tagcgccgtt?cgttgtaact?gagcatgtcg 1260
atgaggcccc?gggcggtgag?ccgctgccgg?ttccgggcca?gatcgcgcgc?ccggggaatc 1320
ggcacccctg?cggggtcggc?ccaggtgagc?cggccacggt?cgtcgatgcg?ggcccggcag 1380
cggttcgcgt?tgtcctggtg?caggcagaac?gggatgtcga?ggtgtccgag?ggcgaacgcg 1440
cgaacgagcg?cctttccgac?atcgctgccg?agggtcagcg?tgtgcgtgat?gatcgcctgg 1500
gcctcctcgt?agatcccgga?gtccggaatt?ccggccggtt?cggccaccgc?ctcccgctcg 1560
gccgcccacg?cggcgcgttc?gagggcgtcg?acgttctccg?tgatcgacgg?gattctgctg 1620
gcctccaccg?cggtcttgac?gatcagccgc?tcggtcccgg?acctggcggc?gagcctcgca 1680
ctctcctcga?g 1691
Claims (9)
1, a kind of nikemycin biosynthetic controlling gene is one of following nucleotide sequences:
1) the SEQ ID № in the sequence table: 1;
2) SEQ ID № in the code sequence tabulation: the polynucleotide of 2 protein sequences.
2, gene according to claim 1 is characterized in that: described gene is the SEQ ID № in the sequence table: 1.
3, nikemycin biosynthetic controlling albumen, it is an aminoacid sequence as SEQ ID №: the protein shown in 2, or with SEQ ID №: 2 amino acid residue sequence is through replacement, disappearance or the interpolation of one or several amino-acid residue and have the № with SEQ ID: 2 is identical active by SEQ ID №: 2 deutero-protein.
4, albumen according to claim 3 is characterized in that: described albumen is amino acid residue sequence as SEQID №: the protein shown in 2.
5, contain the described expression carrier of claim 1.
6, the transgenic engineered bacteria that contains the described gene of claim 1.
7, engineering bacteria according to claim 6 is characterized in that: described engineering bacteria is streptomyces ansochromogenes (Streptomyces ansochromogenes) NK2 CGMCC № 1181.
8, the application of the described gene of claim 1 in nikemycin is produced.
9, the application of streptomyces ansochromogenes (Streptomyces ansochromogenes) NK2 CGMCC № 1181 in nikemycin is produced.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100584112A CN100347302C (en) | 2004-08-11 | 2004-08-11 | Nikkomycin biological synthesis regulating gene and its coded protein and engineering bacterium for expression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100584112A CN100347302C (en) | 2004-08-11 | 2004-08-11 | Nikkomycin biological synthesis regulating gene and its coded protein and engineering bacterium for expression |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1733921A CN1733921A (en) | 2006-02-15 |
CN100347302C true CN100347302C (en) | 2007-11-07 |
Family
ID=36076537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100584112A Expired - Fee Related CN100347302C (en) | 2004-08-11 | 2004-08-11 | Nikkomycin biological synthesis regulating gene and its coded protein and engineering bacterium for expression |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100347302C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101195655B (en) * | 2007-12-07 | 2010-08-25 | 中国科学院微生物研究所 | Regulating protein for polyoxin synthesis, encoding gene and application thereof |
CN101591635B (en) * | 2009-07-02 | 2011-02-02 | 中国科学院微生物研究所 | Recombinant streptomyces ansochromogenes, preparation method thereof and use thereof |
CN102633862B (en) * | 2012-04-25 | 2015-11-18 | 陕西麦可罗生物科技有限公司 | The former medicament preparation of agricultural nikemycin |
CN106148459B (en) * | 2015-04-27 | 2020-06-09 | 牡丹江佰佳信生物科技有限公司 | Fermentation medium and fermentation method of nikkomycin |
CN106337073B (en) * | 2015-07-13 | 2020-02-07 | 牡丹江佰佳信生物科技有限公司 | Fermentation medium and method for increasing output of nikkomycin |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1432644A (en) * | 2002-01-18 | 2003-07-30 | 中国科学院微生物研究所 | Halophilic and alkalophilic bacillus strain and its special plasmid and application |
-
2004
- 2004-08-11 CN CNB2004100584112A patent/CN100347302C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1432644A (en) * | 2002-01-18 | 2003-07-30 | 中国科学院微生物研究所 | Halophilic and alkalophilic bacillus strain and its special plasmid and application |
Non-Patent Citations (1)
Title |
---|
AJ250878. GENEBANK. 2002 * |
Also Published As
Publication number | Publication date |
---|---|
CN1733921A (en) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1197964C (en) | Directed evolution of microorganisms | |
CN1171993C (en) | Novel genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and their use | |
CN1175280A (en) | Novel lysine decarboxylase gene and process for producing L-lysine | |
CN1466630A (en) | Fermentation process for the preparation of L-amino acids using strains of the family enterobacteriaceae | |
CN1288060A (en) | Reproduced freely particles in bar shaped bacteria | |
CN1181202C (en) | Bacillus thuringiensis cryl gene, gene combination and expression vector | |
CN1398964A (en) | Prepn of L-arginine | |
CN100347302C (en) | Nikkomycin biological synthesis regulating gene and its coded protein and engineering bacterium for expression | |
CN1104502C (en) | Genes encoding branched-chain alpha-Ketoacid dehydrogenase complex from streptomyces avermitilis | |
CN1202244C (en) | Novel protein having aspartase activity and gene DNA coding for the same | |
CN1181203C (en) | Bt gene with high toxicity to Lepidoptera and Coleoptera insects, expression vector and engineering bacteria | |
CN1219883C (en) | Engineering systhesized gene cry LC of pests-killing crytal protein of Bacillus thuringiensis Berliner | |
CN1283780C (en) | Method for constructing genetic engineering fungus of monascus with no citrinin | |
CN1527881A (en) | Novel enzymes and genes coding for the same derived from methylophilus methy lot rophus | |
CN1237174C (en) | Temperature sensitive dtsR genes | |
CN1230544C (en) | Hexulose phosphate isomerase and gene coding said isomerase | |
CN1192107C (en) | Novel compound | |
CN1387566A (en) | Cyclic depsipeptide synthases, genes thereof and mass production system of cyclic depsipeptide | |
CN1854154A (en) | Rice blast resistant related protein, its coding gene and use | |
CN1186447C (en) | Streptomyces avermitilis gene directing ratio of B2:B1 avermectins | |
CN1720329A (en) | New expression system from rhodococcus | |
CN1882692A (en) | Selection system containing non-antibiotic resistance selection marker | |
CN1124339C (en) | Novel cell surface protein | |
CN1137806A (en) | Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis | |
CN1186446C (en) | Streptomyces avermitilis gene directing ratio of B2:B1 avermectins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071107 Termination date: 20170811 |
|
CF01 | Termination of patent right due to non-payment of annual fee |